ArticleAnnals of surgical oncology2025
Machine Learning-Driven Modeling to Predict Postdischarge Venous Thromboembolism After Pancreatectomy for Pancreas Cancer.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- AI-Driven Innovations in Transfusion Medicine: A Narrative Synthesis of Current Reviews.Medical sciences (Basel, Switzerland) · 2025Review
- Development and external validation of a machine learning model to predict high flow nasal cannula failure.BMJ open respiratory research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundPostdischarge venous thromboembolism (pdVTE) is a life-threatening complication following resection for pancreatic cancer (PC). While national guidelines recommend extended chemoprophylaxis for all, adherence is low and ranges from 1.5 to 44%. Predicting a patient's pdVTE risk would enable a more tailored approach to extended chemoprophylaxis, better balancing the cost and risks of overtreatment. We aimed to demonstrate the feasibility of using machine learning models to predict pdVTE. PATIENTS AND
methodsWe analyzed data from patients undergoing pancreatectomy for PC using the National Surgical Quality Improvement Program database between 2014 and 2020. Predictive classification models were trained and independently tested on features available at the time of discharge including demographics, clinical, laboratory, cancer, and surgery-specific variables. We developed and compared logistic regression (LR), decision tree (DT), random forest (RF), and gradient boosting (GB) models to predict the development of pdVTE. Model performance and feature importance were evaluated.
resultsThe study included a total of 51,916 patients, with 743 (1.4%) experiencing pdVTE. The best-performing GB, RF, and DT models achieved area under the curve (AUC) scores of 0.83, 0.80, and 0.80, respectively, demonstrating superior performance compared with the traditional LR (AUC = 0.72) model. The GB model achieved a specificity of 99%, sensitivity of 0.40%, and area under the precision recall curve of 0.34. The most important variables were intraoperative antibiotic use, blood transfusion, length of stay, and postoperative infections.
conclusionsMachine learning models can reliably identify patients who are at high risk for pdVTE. Such models should be used to inform prescription of extended VTE prophylaxis.
Indexed as
Identifiers
39979688What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.